Breast Cancer Tissue Array of 150 Samples
      Home >> Welcome to Pantomics                                                                           Price List Download
 

Dedicated facility

 Catalog# BRC1501 - Human breast cancer tissue array

  
Lot# Cores Size Cut Format QA/QC Price
1Slide		 Price
Pack5
BRC150101 150 1.1mm 4um 10X15 H&E, IHC anti-Vimentin/Cytokeratin $150 $600
Order: sales@pantomics.com or call  1-415-863-2380, Form: Word or PDF; PDF data
 
 
Recommended applications: For Research use only. RNA or protein breast cancer/non-tumor tissue profiling using IHC or ISH; Antibody characterization.

Description: Breast cancer tissue array, 150 cores including 75 cases of normal, reactive, premalignant and malignant (various grades and stages) tissues of the breast in duplicates. All the tissues were from surgical resection. They were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They all have a guaranteed six months' shelf-life at 4C from the date of shipment. Each slide has >95% tissue core retention.
 
   

Array
position

Age

Sex

Histology

Grade

Stage (TNM)

AR

ER

PR

HER2

P53

EGFR

Ki67

A1,B1

40

F

Normal/hyperplasia

 

 

++, 5%

++, 5%

++, 2%

-

-

+-

-

A2,B2

30

F

Normal/hyperplasia

 

 

++, 1%

++, 2%

++, 2%

-

-

+-

-

A3,B3

46

F

Normal/hyperplasia

 

 

-

-

-

-

-

-

-

A4,B4

16

F

Fibroadenoma

 

 

-

++~+++, 60%

+++, 50%

-

-

-

-

A5,B5

39

F

Fibroadenoma

 

 

-

-

-

-

-

-

-

A6,B6

28

F

Ductal carcinoma in situ

I

TisN0M0

-

-

-

+++

++~+++, 65%

+-

++, 15%

A7,B7

63

F

Invasive ductal carcinoma

II~III

T4N2M0

-

-

-

-

-

-

-

A8,B8

43

F

Invasive ductal carcinoma

II~III

T2N1M0

-

-

-

-

-

-

-

A9,B9

52

F

Invasive ductal carcinoma

II~III

T2N0M0

-

++~+++, 50%

++~+++, 10%

++

-

-

-

A10,B10

38

F

Invasive ductal carcinoma

III

T4N0M0

-

-

-

-

+-

+

-

A11,B11

74

F

Invasive ductal carcinoma

II~III

T2N0M0

+, 5%

+++, 60%

+, 5%

-

+, 5%

-

+, 5%

A12,B12

49

F

Invasive ductal carcinoma

II

T2N0M0

-

-

-

+++

-

-

-

A13,B13

67

F

Invasive ductal carcinoma

II~III

T4N0M0

-

+, 30%

-

-

-

-

-

A14,B14

60

F

Invasive ductal carcinoma

II~III

T4N2M0

-

-

-

-

-

-

-

A15,B15

53

F

Invasive ductal carcinoma

III

T3N0M0

-

++, 50%

+, 5%

+~++

+, 10%

-

-

C1,D1

47

F

Invasive ductal carcinoma

II

T3N3M0

-

++, 30%

++, 10%

++~+++

-

-

+, 5%

C2,D2

49

F

Invasive ductal carcinoma

II

T2N0M0

++, 5%

+++, 60%

+++, 90%

+~++

-

-

-

C3,D3

55

F

Invasive ductal carcinoma

II~III

T4N2M0

+, 5%

++, 80%

+++, 80%

-

-

-

-

C4,D4

34

F

Invasive ductal carcinoma

III

T3N2M0

-

-

-

-

+-

-

+, 5%

C5,D5

55

F

Invasive ductal carcinoma

II~III

T1N0M0

++, 10%

+++, 80%

+++, 80%

-

-

-

+, 5%

C6,D6

51

F

Paget’s disease

 

TisN0M0

-

-

-

+++

-

-

-

C7,D7

41

F

Ductal carcinoma in situ

I

TisN0M0

++, 15%

++, 60%

+++, 80%

++

-

-

-

C8,D8

43

F

Invasive ductal carcinoma

II

T2N0M0

+, 2%

-

-

+++

-

++*

++, 15%

C9,D9

58

F

Invasive ductal carcinoma

III

T2N2M0

+, 2%

-

-

+++

-

-

++, 5%

C10,D10

41

F

Invasive ductal carcinoma

II

T2N0M0

+, 5%

+++, 80%

+++, 80%

+~++

+-

-

-

C11,D11

44

F

Invasive ductal carcinoma

II~III

T2N0M0

-

++, 60%

++, 10%

+

-

-

-

C12,D12

50

F

Invasive ductal carcinoma

I~II

T2N0M0

-

-

-

+++

++, 5%

++

-

C13,D13

 62

F

Invasive ductal carcinoma

II~III

T4N3M0

+, 5%

++, 50%

+~++, 15%

++

-

-

+-

C14,D14

54

F

Invasive lobular carcinoma

I~II

T2N0M0

-

-

-

-

-

-

-

C15,D15

43

F

Invasive ductal carcinoma

I~II

T2N2M0

-

-

-

+++

-

+

++, 15%

E1,F1

48

F

Invasive ductal carcinoma

II~III

T2N2M0

-

-

+++, 50%

-

-

-

-

E2,F2

40

F

Invasive ductal carcinoma

III

T2N0M0

-

-

-

++

-

++

+, 2%

E3,F3

50

F

Invasive ductal carcinoma

II

T2N0M0

-

-

-

-

-

++~+++

++~+++, 20%

E4,F4

35

F

Invasive ductal carcinoma

II

T2N0M0

++, 2%

+, 5%

++, 50%

-

-

-

++~+++, 20%

E5,F5

92

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

+~++

-

-

-

E6,F6

41

F

Invasive ductal carcinoma

II~III

T2N0M0

-

+, 20%

-

++~+++

+, 5%

-

+, 5%

E7,F7

 58

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

++, 15%

-

-

-

-

E8,F8

28

F

Invasive ductal carcinoma

I~II

T2N0M0

-

++, 50%

-

-

-

-

+, 5%

E9,F9

42

F

Invasive ductal carcinoma

III

T2N0M0

-

-

-

++~+++

-

-

-

E10,F10

50

F

Invasive ductal carcinoma

II~III

T4N3MX

++, 10%

-

-

++

-

+

-

E11,F11

68

F

Invasive micropapillary carcinoma

II~III

T3N1M0

-

++, 20%

-

-

-

-

-

E12,F12

64

F

Invasive ductal carcinoma

II~III

T2N0M0

++, 15%

+, 10%

-

+++

++, 5%?

-

++~+++, 30%?

E13,F13

62

F

Invasive ductal carcinoma

II~III

T2N0M0

++, 20%

+, 10%

-

+++

-?

-

++, 30%?

E14,F14

50

F

Invasive ductal carcinoma

II

T1N0M0

-

-

-

+++

-

+~++

++, 30%

E15,F15

50

F

Invasive ductal carcinoma

II~III

T4N3M1

-

-

-

-

-

-

++, 5%

G1,H1

65

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

-

-

-

++~+++, 60%

G2,H2

47

F

Invasive ductal carcinoma

II~III

T3N2M0

++, 20%

++~+++, 30%

++, 5%

+

-

-

-

G3,H3

53

F

Invasive ductal carcinoma

II~III

T2N1M0

+, 10%

-

-

+++

++~+++, 60%

+++*

-

G4,H4

51

F

Invasive ductal carcinoma

II~III

T4N2M1

++, 50%

+++, 100%

-

-

-

-

++, 2%

G5,H5

51

F

Invasive ductal carcinoma

I~II

T2N2M0

-

-

-

+++

+++, 70%

-

++~+++, 30%

G6,H6

33

F

Invasive ductal carcinoma

III

T2N0M0

++, 5%

-

-

+++

-

-

++, 10%

G7,H7

42

F

Invasive ductal carcinoma

II

T2N0M0

+, 10%

++, 50%

++~+++, 15%

+~++

-

-

++, 40%

G8,H8

48

F

Invasive ductal carcinoma

II~III

T2N0M0

-

++, 50%

+++, 20%

+

++, 60%

-

++, 2%

G9,H9

61

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

+++

++, 60%

-

++, 5%

G10,H10

 49

F

Invasive ductal carcinoma

II~III

T2N0M0

+~++, 10%

-

-

+++

-

-

++~+++, 5%

G11,H11

37

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

-

+++, 80%

++~+++

+++, 80%

G12,H12

44

F

Invasive ductal carcinoma

I

T2N0M0

-

+, 10%

-

+++

-

-

+, 2%

G13,H13

31

F

Invasive ductal carcinoma

II~III

T2N2M0

+, 2%

+, 10%

++, 5%

++~+++

-

+-

+, 5%

G14,H14

36

F

Invasive ductal carcinoma

II

T2N0M0

+, 2%

++, 60%

-

+

-

-

+, 2%

G15,H15

57

F

Invasive ductal carcinoma

II~III

T2N0M0

++, 30%

+++, 50%

-

-

++, 30%

-

++, 2%

I1,J1

52

F

Invasive ductal carcinoma

II

T3N3M0

-

-

-

-

-

+~++*

++, 30%

I2,J2

55

F

Invasive ductal carcinoma

II

T3N0M0

-

+, 20%

++~+++, 20%

+

-

+

+, 2%

I3,J3

37

F

Invasive ductal carcinoma

II~III

T3N1M1

+, 10%

+, 20%

+, 20%

+

-

-

++, 2%

I4,J4

54

F

Invasive ductal carcinoma

II

T2N0M0

-

++, 10%

+, 2%

-

-

-

-

I5,J5

43

F

Invasive ductal carcinoma

II~III

T3N1M0

++, 20%

-

-

+~++

-

+~++

++, 20%

I6,J6

54

F

Invasive ductal carcinoma

III

T2N0M0

-

-

-

+++

++, 60%

-

++, 2%

I7,J7

58

F

Invasive ductal carcinoma

II~III

T3N1M0

-

-

-

-

+-*

-

++, 5%

I8,J8

40

F

Invasive lobular carcinoma

III

T2N0M0

-

++, 50%

++, 15%

-

-

-

++, 5%

I9,J9

 66

F

Invasive ductal carcinoma

II~III

T3N0M0

-

-

-

+++

-

-

+, 2%

I10,J10

29

F

Invasive ductal carcinoma

II~III

T3N1M0

-

-

-

-

-

++

++, 5%

I11,J11

46

F

Invasive ductal carcinoma

II~III

T2N1M0

+, 5%

+, 10%

-

+++

-

-

+, 5%

I12,J12

40

F

Invasive ductal carcinoma

II~III

T3N0M0

++, 5%

+, 15%

+, 5%

-

++~+++, 80%

-

++~+++, 30%

I13,J13

46

F

Invasive ductal carcinoma

II~III

T2N0M0

++~+++, 50%

++, 30%

+++, 80%

+++

++~+++, 30%

-

++, 5%

I14,J14

35

F

Invasive ductal carcinoma

I~II

T4N2M1

++, 5%

++~+++, 60%

+, 5%

+

-

-

+~++, 2%

I15,J15

35

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

+

-

-

+, 2%

 

-------------------------------------------------------------------------------------------------
All Products | Ordering Information | Privacy Policy
Copyright © 2004-2005, Pantomics, Inc. 457 Mariposa Street, San Francisco, CA 94107, USA. Tel: 415-863-2380